Data from Pharmawand - Curated by Toby Galbraith - Date added 17 July 2017

Sunovion has announced that it has entered into a definitive agreement to divest its US marketing rights to Sunovion's ciclesonide products, Alvesco (ciclesonide aerosol) for treatment of asthma , Omnaris (ciclesonide nasal spray) and Zetonna (ciclesonide nasal aerosol) for treatment of allergic rhinitis to Covis N.L. Alvesco, Omnaris and Zetonna were licensed from Takeda GmbH by Sunovion (formerly Sepracor) in 2008.


You will need to login, to leave a comment. is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Airway Disease

The Airway Disease Learning Zone is an area where you can access the information about VisionAir and see video presentations from the forum. The Inhalation Technology page features a video presentation from the live broadcast presented by key faculty.

Visit Airway Disease

Allergic Rhinitis

Allergic rhinitis causes great strain on the workforce. Help to reduce sick days and improve productivity with appropriate treatment options.

Visit Allergic Rhinitis

Related Content